Health
UK to start HEAL-COVID trial to reduce mortality,re-admission rate among Covid survivors – BusinessLine
This will be carried out in collaboration with the Liverpool Clinical Trials Centre at the University of Liverpool and Wrexham-based clinical trial technology firm…
The United Kingdom is set to initiate a drug trial called HEAL-COVID in an effort to alleviate the mortality rate and readmission cases in patients who have previously been hospitalised with the novel coronavirus.
According to the report by Clinical Trials Arena, data collated by the UK Office for National Statistics indicated that 29 per cent of Covid-19 hospitalised patients were readmitted within six months. While more than 12 per cent died within the same period.
So, the new trial will help…
-
Noosa News24 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
General19 hours ago‘Potential’ hacker contacts Qantas over data breach
-
Noosa News5 hours agoHow Lily Steele-Park took her rapist to court and won
-
Business10 hours agoFord CEO makes stunning prediction about artificial intelligence